Evidence map›Paper›PMID 28821265›Full record

ArticleBMC research notes2017

Poncet's disease after the intravesical instillation of Bacillus Calmette-Guérin (BCG): a case report.

Paula Cíntia Machado Sampaio, Yan Garcia Lira, Hellen Yuki Umemura Ribeiro, Fernanda de Paula Moreira, Maitê Silva Martins Gadelha, Sérgio Ferreira Santos da Cruz

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC research notes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Frontiers in cellular and infection microbiology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Paula Cíntia Machado SampaioSection of Oncological Treatment Research, Division of Oncology, Department of Clinical Care, Centro de Tratamento Oncológico, 4402 Mundurucus Street, Guamá, Belém, Pará, 66063-495, Brazil. paulacintia@ig.com.br.
Yan Garcia LiraSection of Clinical Oncology, Division of Oncology, Department of Clinical Care, Universidade do Estado do Pará, 2623 Perebebuí Street, Marco, Belém, Pará, 66087-670, Brazil.
Hellen Yuki Umemura RibeiroSection of Clinical Oncology, Division of Oncology, Department of Clinical Care, Universidade do Estado do Pará, 2623 Perebebuí Street, Marco, Belém, Pará, 66087-670, Brazil.
Fernanda de Paula MoreiraSection of Clinical Oncology, Division of Oncology, Department of Clinical Care, Universidade do Estado do Pará, 2623 Perebebuí Street, Marco, Belém, Pará, 66087-670, Brazil.
Maitê Silva Martins GadelhaSection of Clinical Oncology, Division of Oncology, Department of Clinical Care, Universidade do Estado do Pará, 2623 Perebebuí Street, Marco, Belém, Pará, 66087-670, Brazil.
Sérgio Ferreira Santos da CruzSection of Clinical Oncology, Division of Oncology, Department of Clinical Care, Centro Universitário do Pará, 3775 Almirante Barroso Avenue, Souza, Belém, Pará, 66613-903, Brazil.
Universidade do Estado do Pará · BRCentro Universitário do Pará · BRHospital Santa Paula · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoncet's disease is a rare syndrome characterized by articular impairment in a form of rare tuberculid. One of the theories of its cause involves an autoimmune response induced by the intravesical administration of the Calmette-Guerin Bacillus or the treatment of bladder carcinoma. Furthermore, there may be an appearance of oligoarticular or polyarticular arthritis, beginning 1-3 months after the start of therapy. Few physicians know the disease and the literature related to that syndrome is scarce and restricted to case reports, which contributes to its under diagnosis. CASE PRESENTATION: Female patient, 64 years old, Caucasian, in whom was noticed firstly dark urine, without haematuria or dysuria. Later felt also colic pain in the hypogastric region. Microscopically, the conclusive diagnosis was a high grade non-invasive papillary urothelial carcinoma. Thereupon, the treatment of the tumour began with transurethral resection technique and intravesical instillation of Calmette-Guérin Bacillus as adjuvant treatment. Eight months after the beginning of treatment, the lingering presence of the carcinoma was identified. Nevertheless, arthritis was identified through radiographs, after an increase in the clavicle capitation, right knee and left ankle in bone scintigraphy. Coinciding with the joint manifestations, the patient developed fever and purulent urethral discharge (culture was negative). Therefore, trying to investigate the cause of the arthritis, Purified Protein Derivate was taken, with reactive results. An increase of acute phase reactants was found, with other tests resulting normal: blood chemistry, Complete Blood Count, immunology and serology. Human Leukocyte Antigen typing by polymerase chain reaction revealed the presence of A24/AX, B44, B27, BW4/BW4, DQ7 and DQ5. Consequently, Poncet's disease was the diagnostic conclusion. The treatment with intravesical Calmette-Guérin Bacillus was immediately discontinued. The patient received corticosteroids associated with etoricoxib and isoniazid for 4 months, achieving disappearance of the inflammatory joint signs in 3 months. After 6 months, no joint pain recurrence or other manifestations suggesting active disease had been seen.

conclusionsTherefore, such diagnosis should be considered when confronted with an osteoarticular clinical picture in patients treated with intravesical Calmette-Guérin Bacillus, especially patients with HLA-B27 (+) and B7 (+), as Poncet's disease is a reactive arthritis.

Indexed as

Adjuvants, ImmunologicAdministration, IntravesicalAdrenal Cortex HormonesArthritis, ReactiveCarcinoma, PapillaryEtoricoxibFemaleHumansIsoniazidMiddle AgedMycobacterium bovisPyridinesSulfonesTreatment OutcomeTuberculosisUrinary Bladder NeoplasmsAdjuvants, ImmunologicAdrenal Cortex HormonesEtoricoxibIsoniazidPyridinesSulfonesBladder cancerCase reportIntravesical Calmette–Guérin BacillusPoncet’s diseaseReactive arthritisUrothelial carcinoma

Identifiers

PMID28821265
PMCPMC5563016
OpenAlexW2747568398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.